Patient Voice Agents
P

Paratus Health

Paratus Health builds generative voice agents for outpatient facilities, medical practices, and dental groups. The service handles inbound and outbound patient conversations, including appointment scheduling, intake, insurance eligibility, reminders, and routine billing requests. It also supports transcription and structured documentation for clinicians, with service terms naming SOAP notes among its outputs.

Practices can adapt call flows to their specialties and use outreach to reconnect with inactive patients or recover canceled appointments. Implementation includes reviewing existing phone arrangements, connecting selected numbers, testing a pilot with staff, and expanding across locations. The company describes setup and training within roughly three weeks. Staff can review logged interactions and provide feedback as the service is configured.

A named Clove Dental example reports booking and savings improvements across nine clinics. Other testimonials describe pediatric and obstetric workflows but do not identify the organizations. EHR connections are part of the offering, although current materials differ on which integrations are already available. The privacy policy names OpenAI, Google Cloud, and AWS among processing services. Current answering-service language limits the agents to communication and administrative support, while healthcare professionals retain responsibility for medical decisions. Subscription and implementation terms are arranged with the company for the clinic's requirements.

AI Health Index verifiedOctober 14, 2026
Compare Paratus Health with other vendors
Founded
2024
Headquarters
New York, New York, United States
Categories
patient-facing-voice-agents
Indexed Products
Paratus Voice AI, Patient intake and documentation, Automated patient outreach
Buyer Segments
Outpatient facilities, Medical practices, Dental practices, Multi-site clinic groups
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

Generative voice agents are the service's central interface for patients, rather than an optional analytic feature added to conventional practice software. The agents interpret calls, carry conversations through scheduling or intake tasks, and help produce structured records for staff. Outbound workflows similarly depend on language interaction to reconnect with patients and capture responses.

Telephony, scheduling connections, and administrative rules support those functions, but they do not replace the conversational model's role. Removing that capability would substantially change the primary service offered to practices, even though clinicians remain responsible for any medical decisions informed by a call.

DD on Autonomy and Oversight ModelNo oversight structure is published. An absolute claim that the system does not err grades here too, because a buyer who believes it will not build the review step that would catch a failure.
Vendor Published

The agents can answer, route, and complete routine administrative conversations, with clinic staff involved in setup and ongoing feedback. Current terms acknowledge that AI may need oversight and prohibit sole reliance on its outputs for clinical decisions. Those limits coexist with the homepage's unqualified promise to handle every conversation from beginning to end.

The service does not explain failed interaction thresholds, uncertain intent handling, or mandatory escalation boundaries in enough detail to reconcile that absolute claim. Human responsibility remains explicit, while the product's description of autonomous completion leaves the practical limits of the agent unclear.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them. Naming a supplier is the entry to this band both here and on Model Supply Chain Disclosure, which ask different questions of the same disclosure: who receives the data, and what produces the output.
Vendor Published

The service uses generative AI for natural language calls, intake, and structured clinical documentation. Its privacy policy specifically names OpenAI APIs among processing services, which identifies a model supplier beyond a generic AI description. The terms also distinguish speech and documentation functions from the clinician's decision responsibilities.

Specific deployed models, version identifiers, training populations, evaluation thresholds, and change approval practices remain unspecified. Consequently, a buyer can identify part of the technical approach and supply relationship, but cannot connect the current agent's behavior to a defined model release or reproduce its performance claims.

BB on Model Supply Chain DisclosureSubstantial partial disclosure, or a chain that is structurally short: an in house build, a cleared model that cannot be quietly swapped, or a deployment where the transfer does not occur at all. Naming the model provider exits the band below into this one; the axis rises from here on the completeness of the party list and on the terms that govern data once it arrives.
Vendor Published

The service privacy policy identifies OpenAI, Google Cloud, and AWS, plus EHR providers including Athenahealth and Elation. RingCentral is referenced in the messaging provisions. This is a useful partial list of organizations involved in model processing, hosting, clinical data exchange, or communications. The list is expressly nonexhaustive and does not map each workflow to its processors.

Supplier specific retention periods, training permissions, regional processing commitments, and a complete current subprocessor register remain unspecified. Naming a model provider therefore improves visibility without establishing the contractual protections and data path for every downstream service.

CC on Clinical and Operational EvidenceNamed customers, or vendor reported percentages with no method, denominator or reference standard. Scale of use is recorded here and is not treated as evidence of benefit.
Vendor Published

The Clove Dental example identifies nine clinics and reports 20% more booked appointments within 60 days, together with estimated annual savings and additional visits. It supplies a named customer and a duration, but no calendar dates, underlying appointment counts, comparison design, or evaluation procedure. The savings and revenue figures also combine observed claims with annual estimates.

Other accounts identify roles or specialties without naming the organizations, and some homepage testimonials are described as inspired by clinics. These statements suggest operational use without establishing a reproducible current evaluation or an independent assessment of call quality and patient outcomes.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

PHI is retained for at least six years under the service terms. That wording establishes a minimum retention period rather than a maximum or a promise of deletion at six years. The privacy policy also permits information use for service improvement. Specific model training restrictions, deidentification conditions, deletion of downstream copies, and technical handling of unsafe or fabricated responses remain unspecified. Clinic oversight and activity logs provide a way to review interactions, but they do not complete the account of how sensitive information is reused or how the vendor contains an AI safety incident.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here. A vendor whose product does not process protected health information grades here too when it says so plainly and explains the scope, with a service privacy document behind it: stating a position a buyer can rely on is the posture this axis grades, and the band above is closed to it because there is no agreement to publish.
Vendor Published

The terms identify Paratus as a business associate when it handles PHI for covered entities and state that BAAs apply to covered entities and subcontractors. The service privacy policy covers clinical information such as visit notes, medications, insurance details, and EHR data, rather than only website browsing. It also describes access restrictions, encryption, and permitted sharing for service delivery. These commitments support a substantive healthcare privacy posture. The actual BAA, its coverage of individual features, and any distinctions between trial and production use remain unspecified in the accessible materials.

DD on Security Certifications and Trust CenterControls are asserted with nothing independent behind them, or nothing is published. Read the note before concluding anything: this is the grade most often corrected on a second pass, because assurance material frequently sits on a parent domain or inside an old announcement rather than on the product pages.
Vendor Published

Service controls include encryption during transmission and storage, separate tenant data, and restricted staff access according to role. They address practical risks in a system that handles patient conversations and clinical records. Current independent assurance, the scope of any audit, and an accessible certification artifact remain unverified. These operating controls support a security description, but they do not establish a current externally assessed certification covering the service and its model processing.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance.
Vendor Published

Current answering-service language explicitly excludes diagnosis and treatment and positions the agent as a digital receptionist for communication and administrative work. Scheduling, intake, insurance checks, and call routing are the main current functions. The terms also reserve medical decisions and patient care to healthcare professionals. This provides an express scope boundary for the present offering, with no device clearance claimed for those administrative tasks.

Earlier descriptions of broader clinical ambitions do not establish the intended use or regulatory status of the current release. The current boundary rests on the stated functions and prohibitions rather than a clinical authorization.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

Implementation includes a limited pilot, feedback from clinic staff, adjustment using real calls, and ongoing performance monitoring. This gives customers a practical role in configuring the service and identifying workflow problems before wider rollout. It does not specify a formal AI governance framework, accountable release review body, measurable approval criteria, or independent behavioral audit.

Current patient subgroup comparisons and customer governance review materials remain unspecified. The process therefore describes operational iteration without establishing systematic oversight of model changes or bias.

CC on AI Liability and RecourseMechanisms exist that let someone challenge an output, such as audit trails, source traceability or review before commit, with nothing standing behind the output and no route for the harmed party.
Vendor Published

Activity logs let clinic staff review interactions, and the terms require healthcare professionals to retain clinical responsibility. The liability provisions disclaim responsibility for medical decisions, outcomes, and harm from reliance on AI, with total liability capped at fees paid during the preceding twelve months. Those provisions allocate risk but do not create an output guarantee.

A binding correction obligation, reimbursement for erroneous agent actions, or a defined output dispute process remains unspecified. The practical route described for problems is therefore staff review and ordinary support, without a specific remedy tied to the agent's accuracy.

Integration and Deployment
CC on EHR and Interoperability DepthIntegration is claimed through standards or a middleware layer with no system named and nothing to verify.
Vendor Published

The terms name Athenahealth, eClinicalWorks, and OpenDental and authorize access, transmission, and processing of PHI for agreed tasks. The privacy policy additionally lists Elation. However, the implementation FAQ says integrations with widely used EHRs are still being built and describes secure exports and API connections as alternatives. These statements leave current connector availability and data direction unresolved.

A named production deployment demonstrating a particular read and write workflow is also unspecified. The legal permission to exchange records therefore supports an integration intention without establishing that each named platform already has an operating connection.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

Google Cloud and AWS appear among processing services, and the privacy policy describes tenant isolation and permissions based on staff roles. These are useful architectural controls for keeping organizations' data separate. Its international transfer language says data may be stored or processed in the United States, which is permission rather than an exclusive residency commitment.

Specific hosting regions, model inference locations, backup geography, and cross-border support access remain unspecified. The service therefore identifies parts of its hosted infrastructure and separation model without defining the complete location of patient data throughout processing and storage.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

Fees are set in a subscription or service agreement, and the buying path begins with a consultation or demonstration. The terms explain that nonpayment can lead to service suspension but do not provide a current base subscription, charging unit, included call allowance, or implementation rate. Customer savings and payback examples concern the value of particular deployments. They cannot establish a generally available entry price or the total cost for a clinic's expected call volume.

CC on Setting and Specialty CoverageCoverage is claimed broadly without specifics, or stated clearly with nothing validating it yet.
Vendor Published

The service targets outpatient communication across dental, pediatric, obstetric, orthopedic, and other specialty practices. Specialty specific call flows can reflect different locations, hours, providers, and appointment needs. Clove Dental is a named example spanning nine clinics, while other customer accounts identify a specialty or organizational role without a verifiable organization name. The Texas answering offering also addresses multisite practices and hospital phone access.

This demonstrates intended breadth, but comparable performance across specialties, languages, age groups, and clinical populations remains unspecified. A configurable workflow is not itself validation that the agent handles each population equally well.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Custom quote
Subscription or service agreement BAAs stated for covered entities and subcontractors; agreement terms unspecified Not disclosed Vendor Published

Fees are set by the service agreement. The $2,500 monthly figure listed by a third party is unconfirmed and does not establish a current contract price.